Analgesic Effect of Low Level Laser for Procedural Pain in Newborn Infants
Primary Purpose
Procedural Pain
Status
Completed
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
LaserPen
Sponsored by
About this trial
This is an interventional prevention trial for Procedural Pain focused on measuring neonates, pain, low level laser
Eligibility Criteria
Inclusion Criteria:
- healthy fullterm neonates (37-42 gestational age)
- Apgar score >= 7
- will receive newborn screening
Exclusion Criteria:
- >42 or < 37 gestational age
- perinatal asphyxia
- major malformations or any other disease that need intensive care
- drug withdrawal received previous treatment
Sites / Locations
- Kaohsiung Chang Gung Memorial Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
low level laser group
breast milk group
Arm Description
LaserPen is applied to the local point for 20 seconds where heel-lancing will be performed in the low level laser group.
Subjects in breast milk group are given 5ml expressed breast milk by mouth using a syringe tube inserted to the participant's oral cavity over a 2-minute period before heel-lancing.
Outcomes
Primary Outcome Measures
pain assessment
latency of first cry, crying time, squeezing time, neonatal facial coding system(NFCS), Neonatal Pain, Agitation and Sedation Scale (NPASS)
Secondary Outcome Measures
stress biomarker
The salivary swab method is used to detect the infant's salivary cortisol and amylase level at 3 time point.
Full Information
NCT ID
NCT03268148
First Posted
August 29, 2017
Last Updated
February 26, 2020
Sponsor
Chang Gung Memorial Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03268148
Brief Title
Analgesic Effect of Low Level Laser for Procedural Pain in Newborn Infants
Official Title
Analgesic Effect of Low Level Laser for Procedural Pain in Newborn Infants: an Open-label, Randomized-controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
August 1, 2017 (Actual)
Primary Completion Date
June 30, 2019 (Actual)
Study Completion Date
December 31, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chang Gung Memorial Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Neonates undergo several painful procedures and these pain experiences can alter clinical outcome and behavior. The investigators aim to investigate the analgesic effect of low level laser for procedural pain during heel lancing of term neonates.
Detailed Description
This open-label, randomized controlled trial involves 130 term newborn infants (gestational ages between 37 weeks to 42 weeks) who need heel lancing for newborn screening. Subjects are randomly assigned to low level laser group or breast milk group. Subjects in breast milk group are given 5ml expressed breast milk by mouth using a syringe tube inserted to the participant's oral cavity over a 2-minute period. LaserPen is applied to the local point for 20 seconds where heel-lancing will be performed in the low level laser group. Then heel lancing is performed and two observers who are blinded to the intervention record the physiological (heart rate and oxygen saturation) and behavioral parameters (duration of crying and modified neonatal facial coding scores) following the procedure. Heart rate variation of participants is record by CheckMyHeart ECG monitor. The salivary swab method is used to detect the infant's salivary cortisol and amylase level as biomarker for stress evaluation. During the study course, digital cameras continuously record participants' behavior. Independent t-test, chi-squared test and one way ANOVA are used for statistical analysis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Procedural Pain
Keywords
neonates, pain, low level laser
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
low level laser group and breast milk group
Masking
Outcomes Assessor
Masking Description
Two independent assessors blinded to intervention read the video, and then record vital signs and pain score. The videos are cut from heel-lancing to the end so that the assessors do not know whether the neonate receive low level laser or breast milk.
Allocation
Randomized
Enrollment
123 (Actual)
8. Arms, Groups, and Interventions
Arm Title
low level laser group
Arm Type
Experimental
Arm Description
LaserPen is applied to the local point for 20 seconds where heel-lancing will be performed in the low level laser group.
Arm Title
breast milk group
Arm Type
No Intervention
Arm Description
Subjects in breast milk group are given 5ml expressed breast milk by mouth using a syringe tube inserted to the participant's oral cavity over a 2-minute period before heel-lancing.
Intervention Type
Device
Intervention Name(s)
LaserPen
Other Intervention Name(s)
power 150mW, wavelength 810nm, RJ-laser
Intervention Description
low level laser is used before heel-lancing for newborn screening
Primary Outcome Measure Information:
Title
pain assessment
Description
latency of first cry, crying time, squeezing time, neonatal facial coding system(NFCS), Neonatal Pain, Agitation and Sedation Scale (NPASS)
Time Frame
immediately after heel-lancing
Secondary Outcome Measure Information:
Title
stress biomarker
Description
The salivary swab method is used to detect the infant's salivary cortisol and amylase level at 3 time point.
Time Frame
baseline, immediately after heel-lancing, 20 minutes after heel-lancing
10. Eligibility
Sex
All
Minimum Age & Unit of Time
2 Days
Maximum Age & Unit of Time
4 Days
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
healthy fullterm neonates (37-42 gestational age)
Apgar score >= 7
will receive newborn screening
Exclusion Criteria:
>42 or < 37 gestational age
perinatal asphyxia
major malformations or any other disease that need intensive care
drug withdrawal received previous treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bei-yu Wu, doctor
Organizational Affiliation
Chang Gung Memorial Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kaohsiung Chang Gung Memorial Hospital
City
Kaohsiung
ZIP/Postal Code
833
Country
Taiwan
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
23057434
Citation
Ou-Yang MC, Chen IL, Chen CC, Chung MY, Chen FS, Huang HC. Expressed breast milk for procedural pain in preterm neonates: a randomized, double-blind, placebo-controlled trial. Acta Paediatr. 2013 Jan;102(1):15-21. doi: 10.1111/apa.12045. Epub 2012 Nov 1.
Results Reference
result
Learn more about this trial
Analgesic Effect of Low Level Laser for Procedural Pain in Newborn Infants
We'll reach out to this number within 24 hrs